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Abstract
Background: Plasma triglyceride and high density lipoprotein cholesterol levels are inversely
correlated and both are genetically related. Two correlated traits may be influenced both by shared
and unshared genes. The power to detect unshared trait-specific genes may be increased by
incorporating correlated traits as covariates. The power to localize the shared genes may be
improved by bivariate analysis. Univariate genome scans were carried out on triglyceride (high
density lipoprotein cholesterol) with and without using high density lipoprotein cholesterol
(triglyceride) as a covariate, and bivariate linkage analysis on triglyceride and high density
lipoprotein cholesterol using the 330 Framingham pedigrees of the Genetic Analysis Workshop 13
data. The results of five genome scans were compared to determine the chromosomal regions
which may harbor the genes influencing variation specific to triglycerides, specific to high density
lipoprotein cholesterol, or the covariation of both triglyceride and high density lipoprotein
cholesterol.
Results: The results of our five genome scans identified some chromosomal regions with possible
quantitative trait loci (QTL) that may specifically influence one trait, such as the regions on
chromosome 1 (at 1 cM near marker 280we5), on high density lipoprotein cholesterol, or control
the covariation of both traits, such as the regions on chromosome 7 (at 169 cM near marker
GATA30D09), chromosome 12 (at 3 cM near marker GATA4H03), chromosome 20 (at 49 cM
near marker GATA29F06), chromosome 2 (at 146 cM near marker GATA8H05), and
chromosome 6 (at 148 cM near marker GATA184A08) on triglyceride and high density lipoprotein
cholesterol. The one on chromosome 6 had a LOD score of 3.1 with the bivariate linkage analysis.
Conclusion: There is strong evidence for a QTL on chromosome 6 near marker GATA184A08
appearing to influence the variation of high density lipoprotein cholesterol and triglycerides in the
Framingham population.
Background
Genetic components play important roles in determining
serum lipid levels including plasma triglyceride (TG) and
high density lipoprotein cholesterol (HDL-C) levels. Stud-
ies demonstrate that both TG and HDL-C concentrations
are significantly related to cardiovascular diseases [1,2].
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There is an inverse correlation between TG levels and
HDL-C levels [3,4]. The genetic correlation between TG
and HDL-C is higher compared with environmental cor-
relation. Therefore, the metabolism or genetic back-
grounds of HDL-C and TG may be interrelated. Two
correlated traits could be under the influence of shared
genes, pleiotropy, as well as being influenced by unshared
genes [5]. Bivariate linkage analysis is capable of improv-
ing both the power and localization of the shared gene for
correlated quantitative traits [6]. A study by Arya et al.
showed that the power to detect the unshared genes for a
trait using univariate linkage analysis could be greatly
increased by incorporating other correlated traits as cov-
ariates [7]. On the other hand, the power to detect chro-
mosomal regions harboring shared genes in univariate
linkage analysis may decrease when the corrected trait is
incorporated as a covariate. Here, univariate genome-wide
linkage analyses were performed on TG with and without
HDL-C as a covariate, on HDL-C with and without TG as
a covariate, as well as bivariate linkage analysis on TG and
HDL-C. The results of these five genome scans were com-
pared to identify the chromosomal regions where trait
specific genes for TG, or for HDL-C, or shared genes to
both traits might reside.
Methods
Study population
The real Framingham data (Genetic Analysis Workshop
13 (GAW13), problem 1) were used in this study. The
Framingham Heart Study began in 1948 with the recruit-
ment of 5209 residents, 2336 men and 2873 women aged
28–62 years, from Framingham, Massachusetts. The sub-
jects have undergone biennial examinations since the
study began. In 1971, the Framingham Offspring Study
was initiated, in part, to evaluate the genetic components
of cardiovascular disease etiology. In total, there were
5124 subjects aged 5–70 years recruited. The offspring
subjects have been examined every 4 years (except in the
first two examinations with 8 years intervening). Our
study population included the 330 largest, extended
Framingham families with a total of 1702 genotyped
individuals.
TG, HDL-C, and the other phenotypes used in these anal-
yses were measured at the original cohort examinations
10–12 (TG and HDL-C were measured once for each indi-
vidual over the three examinations) and first offspring
cohort examination. Both cohorts were measured almost
at the same time, in the early 1970s. The measurement of
these phenotypes has been detailed elsewhere [4].
Statistical analysis
Variance-component univariate linkage analysis imple-
mented in SOLAR (1.7.4) [8] was used for heritability esti-
mation, and two-point and multipoint linkage analyses.
This method is based on the assumption of a multivariate
normal distribution for the traits tested, and a violation of
the assumption may result in inflated type I error rates
[9,10]. Since TG and HDL-C are not normally distributed,
with skewness and kurtosis being 2.8 and 14.0 for TG and
0.3 and 1.5 for HDL-C, respectively, logTG and logHDL-C
were used in the analysis. The covariates selected and
incorporated by SOLAR in the heritability estimation and
linkage analysis included age, sex, smoking, and alcohol
consumption. For two separate genome scans logHDL-C
(logTG) was incorporated as a covariate on logTG
(logHDL-C). For the bivariate linkage analyses, a new ver-
sion of SOLAR (2.0.1) used the same covariates as in the
univariate linkage analysis. In this version, bivariate LOD
scores are reported with 1 degree of freedom. These equiv-
alent LOD scores are comparable to univariate LOD
scores.
Results and Discussion
The total number of individuals measured for TG, HDL-C
as well as all covariates used for the heritability estimates
and linkage analyses (age, sex, smoking, and alcohol con-
sumption) was 1999. The correlation between logTG and
logHDL-C was -0.4 (p < 0.01).
The heritability estimates were 44 ± 5% and 40 ± 5% for
logTG and logHDL-C, respectively, after covariate adjust-
ment. The chromosomal regions of the five genome scans
with a maximum multipoint LOD score equal or greater
than 1.5 are summarized in Table 1.
Scans 1 and 2 were genome scans on logTG with and with-
out logHDL-C as a covariate. On scan 1, four regions on
chromosomes 6, 7, 12, and 20 were identified with maxi-
mum multipoint LOD scores equal or great than 1.5.
When logHDL-C was added as an additional covariate in
scan 2, the peak multipoint LOD score decreased for all
four chromosome regions. This result may imply that
those four chromosome regions harbor genes that control
both traits. However, except for the region on chromo-
some 6, these genes might play more important roles in
controlling TG variation than that of HDL-C, since no
strong signal was detected on the HDL-C genome scans
(scans 3 and 4), and the LOD scores for bivariate analyses
were all decreased as well. No new chromosomal region
was identified with a LOD score reaching 1.5 by scan 2.
Our scan 1 was similar to a genome scan of logTG in the
Framingham Heart Study [4]. The two regions on chromo-
some 7 and 20 identified by scan 1 were also identified by
their study. In addition, a new region on chromosome 6
was identified with a maximum LOD score of 1.7. Basi-
cally, we used the same data. However, because only a
limited number of variables from the Framingham data
were provided to GAW13, our study did not include asBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S47
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many covariates in the analyses as in theirs. In contrast, we
did not include body mass index (BMI) as a covariate,
because we considered BMI as a correlated trait of both TG
and HDL-C, and to include it as a covariate may decrease
the power to detect a shared gene effect. Interestingly, the
results of our other genome scans provided evidence that
the chromosome 6 region may harbor a gene controlling
both TG and HDL-C, the same region that was identified
by a previous genome scan for BMI [11].
Scans 3 and 4 were of logHDL-C with and without logTG
as a covariate. On scan 3, two chromosome regions were
Table 1: The highest multipoint LOD scores equal or greater than 1.5A
1:logTGB 2: logTGC 3:logHDL-CB 4:logHDL-CD 5:logTG&logHDL-CB
Chr cM LOD Chr cM LOD Chr cM LOD Chr cM LOD Chr cM LOD
61 4 8 1 . 7 ( 6 1 4 1 1 . 2 ) ( 1 10 . 8 ) 111 . 6 ( 1 11 . 0 )
7 169 1.5 (7 169 0.6) 2 146 2.6 2 141 1.7 2 146 1.7
12 3 1.5 (12 3 1.0) 6 149 2.9 6 141 2.4 6 148 3.1
20 49 2.1 (20 49 1.3) (7 171 0.9)
(12 3 0.7)
(20 49 1.3)
AIf the maximum LOD score in one scan reaches 1.5, the results of the correspondent chromosome region in another scan, with or without the 
second trait as a covariate (e.g., between scan 1 and scan 2 or between scan 3 and scan 4), were also reported even though the LOD scores may 
not reach 1.5 (in parenthesis). In the bivariate linkage analyses, in addition to those chromosome regions with LOD score 1.5 or higher, the results 
of other chromosome regions which have been identified in scan 1 through scan 4 are also displayed. BWith covariates age, sex, alcohol, and 
smoking. CWith covariates age, sex, alcohol, smoking, and logHDL-C. DWith covariates age, sex, alcohol, smoking, and logTG.
The results of five genome scans on chromosome 6 Figure 1
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identified with maximum LOD scores equal to or greater
than 1.5 (LOD = 2.6 and 2.9 on chromosome 2, at 146 cM
and chromosome 6, at 149 cM, respectively). When an
additional covariate, logTG, was included, the peak LOD
score on chromosome 2 decreased from 2.6 to 1.7, and
the peak LOD score on chromosome 6 decreased slightly
from 2.9 to 2.6. This may indicate that these two regions
harbor shared genes controlling the covariation for both
traits, and that the shared gene on chromosome 2 may
play a greater role in controlling the variation of HDL-C
than that of TG, because this region was not identified by
the scans of logTG. In the bivariate linkage analyses, the
LOD score on the chromosome 6 region at 148 cM
increased (LOD = 3.1) (Figure 1). This supports the idea
that the gene in this region is involved in controlling cov-
ariation of both traits. Scan 4, the genome scan of
logHDL-C with logTG as a covariate, identified one chro-
mosomal region, chromosome 1 at 1 cM, with a maxi-
mum LOD score of 1.6. The LOD score increased
compared to that of scan 3, without logTG as a covariate.
This may be evidence that a putative locus specific to
HDL-C may be in this region. In the bivariate linkage
analyses, the LOD score in this region was decreased com-
pared with that of scan 4. This is further evidence that the
gene in this region may be related to HDL-C variation
only, instead of being a shared gene.
The region on chromosome 6 with highest multipoint
LOD scores in the last three genome scans is near marker
D6S1009-GATA184A08. Interestingly, the same region
was identified by a genome scan of TG as well as BMI, a
TG and HDL-C related trait, in nondiabetic Mexican
Americans [11].
Conclusions
In conclusion, the results of our five genome scans identi-
fied chromosomal regions in which QTL may reside and
that might influence one of the traits, such as HDL-C, or
control the covariation of both traits, TG and HDL-C.
There is strong evidence for a QTL on chromosome 6 near
marker GATA184A08 appearing to influence the covaria-
tion of HDL-C and TG in the Framingham population.
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